Ryosuke Goto

Guselkumab, a human interleukin‐23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52‐week, phase 3, multicenter, open‐label study

Shigetoshi Sano, Hiroshi Kubo, Hitomi Morishima et al. · The Journal of Dermatology · 2018 · 128 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Guselkumab, an anti‐interleukin‐23 monoclonal antibody, for the treatment of moderate to severe plaque‐type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double‐blind, placebo‐controlled study

Mamitaro Ohtsuki, Hiroshi Kubo, Hitomi Morishima et al. · The Journal of Dermatology · 2018 · 109 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis

Tadashi Terui, Satomi Kobayashi, Yukari Okubo et al. · JAMA Dermatology · 2019 · 102 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study

Nagahide Takahashi, Aya Yamada, Ayako Shiraishi et al. · BMC Psychiatry · 2021 · 56 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17